INBS
INTELLIGENT BIO SOLUTIONS INC.
+0.04 (+2.03%)2.01USD13.1K成交股數6.1M市值–本益比(近四季)1.4股價營收比+45.5%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | 03-20 | Simeonidis Harry | Chief Executive Officer | A 獲配股票 | 9.2K | – | – | 13.2K | SEC |
| 2026-03-18 | 03-20 | Simeonidis Harry | Chief Executive Officer | A 獲配股票 | 21.4K | – | – | 34.5K | SEC |
| 2026-03-18 | 03-20 | Hurd Jonathan Scott | Director | A 獲配股票 | 5.0K | – | – | 5.0K | SEC |
| 2026-03-18 | 03-20 | Isenberg Jason | Director | A 獲配股票 | 5.0K | – | – | 5.0K | SEC |
| 2026-03-18 | 03-20 | Sakiris Spiro Kevin | Chief Financial Officer | A 獲配股票 | 9.2K | – | – | 12.6K | SEC |
| 2026-03-18 | 03-20 | Sakiris Spiro Kevin | Chief Financial Officer | A 獲配股票 | 21.4K | – | – | 34.0K | SEC |
| 2026-03-18 | 03-20 | Fraser Nicola Marion | Director | A 獲配股票 | 5.0K | – | – | 5.0K | SEC |
| 2026-03-18 | 03-20 | Boyages Steven Constantine | Director | A 獲配股票 | 5.0K | – | – | 5.0K | SEC |
| 2024-09-25 | 03-31 | Sakiris Spiro Kevin | Chief Financial Officer | A 獲配股票 | 34.5K | – | – | 34.8K | SEC |
| 2024-09-25 | 09-27 | Sakiris Spiro Kevin | Chief Financial Officer | A 獲配股票 | 34.5K | – | – | 34.8K | SEC |
| 2024-09-25 | 09-27 | Simeonidis Harry | Chief Executive Officer | A 獲配股票 | 40.0K | – | – | 40.4K | SEC |
| 2024-03-20 | 03-21 | Sakiris Spiro Kevin | Chief Financial Officer | X 選擇權履約 | 9.4K | – | – | 19.2K | SEC |
| 2023-10-04 | 10-06 | Sakiris Spiro Kevin | Chief Financial Officer | P 公開市場買進 | 113K | – | – | 117K | SEC |
| 2023-10-04 | 10-06 | TOWERS CHRISTOPHER | Director | P 公開市場買進 | 9.1K | – | – | 9.9K | SEC |
| 2023-09-01 | 09-05 | Simeonidis Harry | CEO | P 公開市場買進 | 50 | 1.85 | 92.50 | 4.2K | SEC |
| 2023-08-31 | 09-05 | Simeonidis Harry | CEO | P 公開市場買進 | 100 | 1.92 | 192.00 | 4.1K | SEC |
| 2023-05-10 | 07-11 | Sakiris Spiro Kevin | Chief Financial Officer | C 轉換 | 2.4K | 5.80 | 14K | 4.7K | SEC |
| 2022-10-10 | 10-12 | Simeonidis Harry | President | A 獲配股票 | 80.0K | – | – | 80.6K | SEC |
| 2022-10-10 | 10-12 | Hurd Jonathan Scott | Director | A 獲配股票 | 15.0K | – | – | 15.0K | SEC |
| 2022-10-10 | 10-12 | Sakiris Spiro Kevin | Chief Financial Officer | A 獲配股票 | 75.0K | – | – | 125K | SEC |
| 2022-10-10 | 10-12 | Boyages Steven Constantine | Interim CEO and Chairperson | A 獲配股票 | 75.0K | – | – | 75.0K | SEC |
| 2022-10-10 | 10-12 | FISHER LAWRENCE B | Director | A 獲配股票 | 15.0K | – | – | 15.0K | SEC |
| 2022-10-10 | 10-12 | Margelis George | Director | A 獲配股票 | 15.0K | – | – | 15.0K | SEC |
| 2022-10-10 | 10-12 | TOWERS CHRISTOPHER | Director | A 獲配股票 | 15.0K | – | – | 15.8K | SEC |
| 2022-06-22 | 06-24 | Sakiris Spiro Kevin | Chief Financial Officer | P 公開市場買進 | 5.0K | 0.65 | 3K | 50.2K | SEC |
| 2022-06-17 | 06-22 | Sakiris Spiro Kevin | ChiefFinancial Officer | P 公開市場買進 | 16.0K | 0.61 | 10K | 45.2K | SEC |
| 2022-02-17 | 02-22 | Life Science Biosensor Diagnostics Pty Ltd | Other | S 公開市場賣出 | 576K | 0.51 | 294K | 1.1M | SEC |
| 2022-02-16 | 02-18 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.63 | 63K | 1.7M | SEC |
| 2022-02-15 | 02-17 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.68 | 68K | 1.8M | SEC |
| 2022-02-14 | 02-17 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.70 | 70K | 1.9M | SEC |
| 2022-02-11 | 02-17 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.75 | 75K | 2.0M | SEC |
| 2022-02-10 | 02-15 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.84 | 84K | 2.1M | SEC |
| 2022-02-09 | 02-11 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.86 | 86K | 2.2M | SEC |
| 2022-02-08 | 02-10 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.89 | 89K | 2.3M | SEC |
| 2022-02-02 | 02-08 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.92 | 92K | 2.4M | SEC |
| 2022-01-31 | 02-03 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.90 | 90K | 2.5M | SEC |
| 2022-01-28 | 02-01 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 0.92 | 92K | 2.6M | SEC |
| 2022-01-27 | 02-01 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 1.00 | 100K | 2.7M | SEC |
| 2021-12-30 | 01-03 | Parmakellis Tom | Director | P 公開市場買進 | 4.5K | 1.55 | 7K | 9.3K | SEC |
| 2021-12-17 | 12-21 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 200K | 1.49 | 298K | 2.8M | SEC |
| 2021-12-16 | 12-20 | Parmakellis Tom | Director | P 公開市場買進 | 2.8K | 1.69 | 5K | 4.8K | SEC |
| 2021-12-06 | 12-07 | Sakiris Spiro Kevin | ChiefFinancial Officer | P 公開市場買進 | 10.0K | 1.70 | 17K | 29.3K | SEC |
| 2021-11-30 | 12-03 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 250K | 1.87 | 468K | 3.0M | SEC |
| 2021-11-29 | 12-01 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 1.69 | 169K | 3.2M | SEC |
| 2021-11-24 | 11-29 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 1.64 | 164K | 3.3M | SEC |
| 2021-11-09 | 11-12 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 300K | 2.02 | 606K | 3.4M | SEC |
| 2021-10-21 | 10-25 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 248K | 2.26 | 561K | 3.7M | SEC |
| 2021-10-20 | 10-22 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 24.2K | 2.25 | 54K | 4.0M | SEC |
| 2021-10-19 | 10-21 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 16.3K | 2.25 | 37K | 4.0M | SEC |
| 2021-10-14 | 10-18 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 101K | 2.18 | 220K | 4.0M | SEC |
| 2021-10-13 | 10-15 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 58.7K | 2.25 | 132K | 4.1M | SEC |
| 2021-10-12 | 10-14 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 2.13 | 213K | 4.2M | SEC |
| 2021-10-08 | 10-12 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 200K | 2.30 | 460K | 4.3M | SEC |
| 2021-09-28 | 09-30 | Parmakellis Tom | Director | P 公開市場買進 | 1.0K | 2.40 | 2K | 2.0K | SEC |
| 2021-09-28 | 09-30 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 200K | 2.48 | 496K | 4.5M | SEC |
| 2021-09-24 | 09-28 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 200K | 2.66 | 532K | 4.7M | SEC |
| 2021-09-23 | 09-27 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 2.77 | 277K | 4.9M | SEC |
| 2021-09-22 | 09-24 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 2.80 | 280K | 5.0M | SEC |
| 2021-09-21 | 09-23 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 2.83 | 283K | 5.1M | SEC |
| 2021-09-20 | 09-22 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 100K | 2.90 | 290K | 5.2M | SEC |
| 2021-09-17 | 09-22 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | S 公開市場賣出 | 45.2K | 3.29 | 149K | 5.3M | SEC |
| 2021-06-21 | 06-28 | Parmakellis Tom | Director | P 公開市場買進 | 1.0K | 4.44 | 4K | 1.0K | SEC |
| 2021-05-19 | 05-21 | Sakiris Spiro Kevin | Chief Financial Officer | P 公開市場買進 | 10.0K | 3.07 | 31K | 16.3K | SEC |
| 2021-03-02 | 03-03 | Gavrilenko Victoria | Director | P 公開市場買進 | 37 | 8.09 | 296.34 | 37 | SEC |
| 2021-02-24 | 02-25 | TOWERS CHRISTOPHER | Director | P 公開市場買進 | 800 | 6.84 | 5K | 800 | SEC |
| 2021-01-18 | 01-21 | Life Science Biosensor Diagnostics Pty Ltd | TenPercentOwner | X 選擇權履約 | 118K | – | – | 5.8M | SEC |
| 2021-01-04 | 02-16 | Chief Financial Officer | X 選擇權履約 | 1.5K | – | – | 6.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 141K | 325K | +11.4K (+9%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 20.8K | 48K | −7.8K (-27%) | 減碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.8K | 13K | 不變 | 持平 |
| UBS Group AG | 5.7K | 13K | +5.4K (+1442%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 4.0K | 9K | 不變 | 持平 |
| Tower Research Capital LLC (TRC) | 3.3K | 8K | +2.0K (+162%) | 加碼 |
| OSAIC HOLDINGS, INC. | 200 | 460.00 | 不變 | 持平 |
| BARCLAYS PLC | 142 | 326.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 8 -1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1 / 2 / 3 / 1 |
| 機構合計持股 · 佔流通股 | 181K · 6.0% |
| 合計季末市值 | 416K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 33.7K |
|---|---|
| 與上期比 | -68.0% |
| 佔流通股數 | 1.11% |
| 日均成交量 | 90.6K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 33.7K | -68.0% | 1.11% | 90.6K | 1.0 |
| 2026-08-14 | 105K | +112.8% | 3.47% | 111K | 1.0 |
| 2026-07-31 | 49.4K | -52.2% | 1.63% | 101K | 1.0 |
| 2026-07-15 | 103K | +21.3% | 3.41% | 60.9K | 1.7 |
| 2026-06-30 | 85.2K | -19.9% | 2.81% | 37.3K | 2.3 |
| 2026-06-15 | 106K | +16.7% | 3.51% | 68.7K | 1.6 |
| 2026-05-29 | 91.2K | -38.8% | 3.01% | 111K | 1.0 |
| 2026-05-15 | 149K | +172.7% | 4.92% | 248K | 1.0 |
| 2026-04-30 | 54.6K | +102.2% | 1.80% | 110K | 1.0 |
| 2026-04-15 | 27.0K | -39.3% | 0.89% | 130K | 1.0 |
| 2026-03-31 | 44.5K | +0.2% | 1.47% | 42.9K | 1.0 |
| 2026-03-13 | 44.4K | -53.0% | 1.47% | 52.3K | 1.0 |
| 2026-02-27 | 94.4K | +181.7% | 3.12% | 129K | 1.0 |
| 2026-02-13 | 33.5K | -74.6% | 1.11% | 90.3K | 1.0 |
| 2026-01-30 | 132K | -64.3% | 4.35% | 172K | 1.0 |
| 2026-01-15 | 369K | +187.3% | 12.20% | 3.4M | 1.0 |
| 2025-12-31 | 129K | -86.5% | 4.25% | 9.8M | 1.0 |
| 2025-12-15 | 951K | +4.0% | 31.42% | 176K | 5.4 |
| 2025-11-28 | 915K | -3.2% | 30.21% | 115K | 8.0 |
| 2025-11-14 | 945K | +14.1% | 31.21% | 304K | 3.1 |
| 2025-10-31 | 828K | +57.1% | 27.34% | 576K | 1.4 |
| 2025-10-15 | 527K | +8.6% | 17.40% | 135K | 3.9 |
| 2025-09-30 | 485K | +8.8% | 16.03% | 405K | 1.2 |
| 2025-09-15 | 446K | -10.0% | 14.73% | 139K | 3.2 |
| 2025-08-29 | 495K | -14.1% | 16.36% | 119K | 4.2 |
| 2025-08-15 | 577K | +7.3% | 19.05% | 132K | 4.4 |